Industry Insights
-
Cryogenic Transport For Gene Therapy Products — The Pros And Cons
3/21/2019
Temperature-controlled packages used for the transport of gene therapy products use a combination of thermal insulators or thermoregulators to decrease the heat transfer rate from outside of the shipper to the inside. In this two-part article, we will explore common methods of temperature-controlled transportation and delve into their pros and cons. In Part 1, we focus on passive cryogenic options.
-
A Practical Proposal For Standardizing Traceability Of Cell And Gene Therapies
7/21/2023
For personalized therapies, it is imperative that patients are treated with the product meant specifically for them. Mistakes in products or on labels that lead to the wrong therapy being administered to the patient are likely to have fatal consequences. BioPhorum presents a practical vision for standardizing the traceability of cell and gene therapies across the value chain.
-
3 Key Trends Shaping The CDMO Industry In 2024 And Beyond
It is essential for biopharma companies to stay up to date on the future of CDMOs. Read about three key trends that are helping shape the CDMO industry.
-
Why Robotic Sterile Fill-Finish Is Key For Speed To Clinic And Patient Safety
10/26/2022
Robotic technology and the use of “isolator-barrier systems” are the core technologies that are advancing sterile fill-finish delivering product purity assurance.
-
Why So Slow? Demystifying The Barriers To U.S. Biosimilar Adoption
12/19/2017
This article will provide a glimpse into the complex and often misunderstood dynamics of U.S. biosimilar reimbursement that contribute to the state of the market today — a topic that is particularly salient in light of recent policy changes by the Centers for Medicare & Medicaid Services (CMS).
-
Plugging India Into The Global Cold Chain With Effective Monitoring, Compliance And Registration
5/22/2014
India is a hot topic in the food industry currently, as a result of the EU imposing a ban on the import of mangoes from the country due to quality issues.
-
Supply Chain Risk Where You Least Expect It — Good Supply Practices For The Life Sciences
8/7/2017
The medtech, pharma, and biotech industries are concerned about their inability to consistently ensure the supply of incoming materials. This article offers recommendations for good supply practices - assembled by a team of FDA officials and industry professionals - that reduces the risk to finished product quality, patient safety, and business success.
-
How To Hire A Qualified Contingent Recruiter
8/7/2023
It is important for the pharma, biopharma, and medical device industries to obtain the most qualified candidates during these fast-paced technological times for either the short- or long-term (i.e., specialized consultants) or direct hire full-time employees. In this article, we focus on hiring the right qualified contingent recruiter (contingency and retained search).
-
CAR T-Cell Therapies: Current Limitations & Future Opportunities
9/26/2019
Novel technologies to address areas left unaddressed by Kymriah and Yescarta have started streaming into the research arena. This article focuses on the barriers to widespread commercial adoption of the currently available CAR T cell therapies, and opportunities for developers of next-generation treatments.
-
Pharma 4.0: Building Quality Into Pharma Manufacturing, From Molecule To Medicine
10/1/2019
A race is being run to create the pharmaceutical manufacturing of the future and with Pharma 4.0, powerful market trends are shaping the running field.